The transcobalamin (TC, TCII) receptor (TCblR) on the plasma membrane binds TCcobalamin (Cbl) and internalizes the complex by endocytosis. This receptor was purified 
the lysosome and the free Cbl released is converted into Cbl cofactors 4, 5 .
Methylcobalamin is a cofactor for the cytosolic enzyme methionine synthase in the conversion of homocysteine to methionine using N 5 -methyltetrahydrofolate 6 and therefore homocysteine is elevated in both Cbl and folate deficiency 7 . The mitochondrial enzyme methylmalonyl CoA mutase converts methylmalonyl CoA to succinyl CoA and requires 5'deoxyadenosylcobalamin as a cofactor. The elevated methylmalonic acid in Cbl deficiency is a direct consequence of a block in this pathway 8 . The definitive purification of TC 9 followed by the identification of vascular endothelium as the source of TC in blood 10 ultimately led to the cloning of the cDNA and the gene encoding this protein 11, 12 . Attempts to purify the receptor have yielded ambiguous results 13, 14 , however, the functional properties of TCblR have been well characterized in cell culture models 15, 16 . We have previously described the functional and structural properties of TCblR based on binding of TC-Cbl to TCblR from human placenta and by crosslinking studies 17, 18 . Our data on the properties and structure of this receptor differs from two other reports describing the purification of this protein 13, 14 . The report by Bose et al 14 described a receptor with different structural constituents. Since their first report, numerous publications by this group have described the structural and functional characterization of a putative receptor from human placenta [19] [20] [21] [22] [23] [24] [25] . However, they did not establish the functional specificity of their receptor for TC-Cbl and have not identified the primary structure and the gene encoding the receptor. This report describes the purification and definitive identification of the primary structure and the gene encoding a receptor for the cellular uptake of TC-Cbl. This unique receptor has the specificity and
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From affinity required for the cellular uptake of holo TC and differs from the 72 / 144 kDa monomer / dimer protein reported to be the receptor for TC-Cbl 14 .
Materials and Methods:
Actigel The procurement of fresh human placentas, preparation of membranes, measuring TC-Cbl binding in membranes, solubilization of receptor activity and determination of TC-Cbl binding activity in the soluble fraction are described in our previous publications 17, 18 .
For large-scale solubilization of membrane proteins, 400-800 g of membranes were homogenized in 2.5 volumes of buffer (20mM Tris/150mM NaCl/1mM PMSF pH 7.5) and Empigen BB, a nonionic detergent was added to a final concentration of 0.5% in 3 volumes of buffer. The membranes were mixed overnight at 4 o C, pelleted at 15,000g for 20 min. and the supernatant fraction subjected to 100,000g centrifugation to obtain the soluble protein fraction. NaCl/0.5% Empigen/pH 7. 5) at 4 o C and after 1 hr, 100 ul of a 50% suspension of lectinagarose is added and the incubation continued for an additional hour with constant mixing. One ml of Buffer 1 is added to each tube, and the agarose pelleted at 1000 rpm for 5 min, washed once with 1 ml Buffer 1 and the radioactivity in the pellet determined.
Less than 2% of the radioactivity is associated with the lectin-agarose in 10 mM EDTA or when the TCblR is excluded from the reaction.
Affinity purification of the receptor protein:
Our previous experience with the application of conventional as well as ligand specific affinity purification techniques for the isolation of the soluble receptor protein from human placental membranes 17 resulted in low recovery and lack of purity. This was attributed to loss of functional activity and multiple proteins non-specifically binding to the Cbl -TC affinity matrix and eluting with EDTA. With the primary objective of obtaining a homogeneous protein band by SDS-PAGE for definitive identification of the protein by LC-MS, a three-step affinity purification strategy was applied. followed by 250mM NaCl (10 ml) and 500mM NaCl (8 ml) in Buffer 1. Additional washing was done with Buffer 1 without any NaCl (8 ml) and with 0.1M MgCl 2 (8 ml) and 0.2M MgCl 2 (8 ml : We have previously reported the purification of human TC 9 using Cbl that is covalently attached to a matrix whereby the cobalt of Cbl is linked to the matrix by an aminopropyl spacer 27 . This matrix can be used to bind TC and the TC-Cbl on the matrix will then serve as the affinity ligand to capture the receptor protein. Because the cobalt carbon bond is photo-labile, the Cbl-TC-TCblR complex formed can be released from the matrix by simply exposing the matrix to white light such as a 300W lamp. One disadvantage of this procedure is that both TC and TCblR are released as a complex and the affinity matrix cannot be reused.
However, the protocol eliminates many of the contaminant proteins that elute from the matrix with MgCl 2 or EDTA.
The aminopropyl Cbl was synthesized and purified as previously described 27 and was coupled to Ultralink matrix as per instructions provided by the manufacturer. For largescale purification using this procedure, the affinity matrix was prepared by mixing 1 ml of the Cbl-aminopropyl-Ultralink matrix with 0.5 mg of partially purified apo rhTC. This provided ~10-11 nano moles of TC on the matrix. The matrix was extensively washed with buffers as described previously for the purification of TC 9 . The eluted fractions from the first affinity matrix were assayed for functional activity, pooled, dialyzed against
Buffer 1 and mixed with the affinity matrix overnight. The matrix was recovered, washed batch-wise twice with 50 ml of Buffer 1, transferred to a column and washed with 15 ml of 20mM Tris/150mM NaCl/5mM CHAPSO, pH 7.5. The column was clamped, 1 ml of 20mM Tris/300mM NaCl/5mM CHAPSO, pH 7.5 was added and the matrix was exposed to a 300W tungsten lamp placed ~20 cm above the matrix and the TCblR-TC-Cbl complex was released by photo-dissociation of the Cbl from the matrix as described for the purification of TC 9 . The matrix was kept cold by placing the column in ice and by dissipating the heat from the lamp with a portable blower. After 1 hr, the buffer in the column was drained and the matrix washed with 1 ml of buffer. The photolysis was repeated two additional times and the elutions were pooled. CHAPSO. The eluting buffer was collected and the matrix was washed with another ml of the same buffer. This sample was dialyzed, concentrated and separated in an 8%
reducing SDS-PAGE gel and the protein stained with coomassie blue dye. The band corresponding to the size of TCblR was excised, digested with trypsin and analyzed by LC-MS. Peptide peaks were subjected to further MS-MS analysis to yield amino acid sequences. The raw data files were processed using the MassLynx ProteinLynx software and the data files were submitted to WWW.matrixscience.com for protein matching using the mascot algorithm.
Results:
A definitive measure of receptor protein as determined by binding of TC-Cbl was critical for monitoring the receptor activity during solubilization and purification of Extensive dialysis in the presence of Ca ++ was necessary to recover at best partial functional activity. Low yield of the functional receptor coupled with loss of activity during purification, made it difficult to process large volumes of the solubilized receptor through multiple purification steps to obtain adequate amounts of a homogeneous single protein with functional activity. Therefore, different elution approaches and three separate affinity purification steps were applied to obtain the pure protein. From the initial affinity purifications, it appeared that a large number of proteins were sticking to the matrix nonspecifically or by a Ca ++ dependent mechanism and were eluting with EDTA used in the initial purification or the MgCl 2 used in the later purification. In order to circumvent this problem, we decided to test a different elution procedure. We had previously shown that the TCblR-TC-Cbl complex could be released from the aminopropyl Cbl-TC affinity matrix by photo-dissociation of the matrix bound Cbl 18 . We adapted this procedure for the second affinity purification step. Even though this procedure was deemed not practical for large-scale purification, it was done to circumvent the problems associated with the MgCl 2 elution. The obvious disadvantages of this procedure are that all of the TC on the affinity matrix is released contributing to a large amount of non-receptor protein and the affinity matrix cannot be reused. In order to remove most of the TC not bound to the receptor, the protein released from the second affinity purification step, was further purified through a Con A-agarose lectin column. 
Discussion:
Since the first demonstration of a B12 binding protein in serum needed for the uptake of vitamin B12 in tissues 1 , the search for a membrane receptor that specifically binds the plasma protein saturated with B12 has continued for the past several decades. During this period, it was unequivocally established that the plasma protein necessary for cellular uptake of Cbl is transcobalamin and that a receptor protein expressed on the plasma membrane of all cell types specifically binds TC saturated with Cbl 29 . The binding requires the divalent cation Ca ++ and could be blocked by a molar excess of a chelator such as EDTA or EGTA. This binding was saturable and required metabolic energy for expression of the receptor protein and for cellular uptake of the Cbl 15 . Purification of this receptor proved to be problematic because of the low level of expression and complex multi step procedures such as functional affinity purification and assay to accomplish this. Placenta is one human tissue that can be readily obtained and proved to be the source of membranes for further characterization and purification of the receptor protein.
The first attempted purification of the receptor reported by Seligman and Allen
13
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From described a triton soluble 50kDa protein with comparable affinity for both apo and holo TC. Their procedures proved difficult to reproduce in our hands and subsequently led to a detailed characterization of the receptor protein 17 with results that contradicted many of their earlier conclusions. In 1995 Bose et al 14 published the characterization of a receptor protein using the procedure of Seligman and Allen 13 . They identified a 72kDa / 144kDa monomer / dimer as the receptor protein 14 and followed with a number of publications describing the complex physio-chemical properties of this receptor [19] [20] [21] [22] [23] [24] [25] The lack of progress in identifying the gene encoding the receptor for nearly ten years following their first report claiming purification of substantial quantities of the receptor protein, For
